Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer

OBJECTIVE: To examine survival outcomes of women with recurrent cervical cancer who received salvage chemotherapy with modified dose-dense paclitaxel (MDDP) monotherapy (paclitaxel 80 mg/m(2), administered on day 1, 8, and 15 without day 22). MATERIALS AND METHODS: A retrospective study was conducte...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Clin Oncol
Main Authors: Machida, Hiroko, Moeini, Aida, Ciccone, Marcia A., Mostofizadeh, Sayedamin, Takiuchi, Tsuyoshi, Brunette, Laurie L., Roman, Lynda D., Matsuo, Koji
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7528455/
https://ncbi.nlm.nih.gov/pubmed/28763329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000394
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki